Literature DB >> 4629257

Identification of different measles virus-specific antibodies in the serum and cerebrospinal fluid from patients with subacute sclerosing pancencephalitis and multiple sclerosis.

A A Salmi, E Norrby, M Panelius.   

Abstract

Matched serum and cerebrospinal fluid (CSF) samples from eight cases of subacute sclerosing panencephalitis (SSPE) and 15 cases of multiple sclerosis (MS) were characterized in neutralization, hemolysis-inhibition (HLI), hemagglutination-inhibition (HI) with Tween 80-ether-treated antigen, complement-fixation (CF), and immunodiffusion tests. CF tests were carried out with crude virus material, purified nucleocapsids, and small particle hemagglutinin as antigens. A certain diversity in the relative content of antibodies against different virus products in various sera was found. There was a high degree of correlation between titers of neutralizing and HLI antibodies, but a less strict correlation between titers of HLI and HI antibodies. Serum samples from two cases of MS and one case of SSPE contained high titers of HLI and neutralizing antibodies in the presence of only low titers of HI antibodies demonstrable with Tween 80-ether-treated antigen. The major fraction of antibodies detected in CF and immunodiffusion tests reacted with nucleocapsids. There was a tendency of nucleocapsid CF antibody titers, as compared to neutralization and HLI antibody titers, to be higher in samples from patients with SSPE than from cases of MS. No significant differences were found between antibody titers recorded in neutralization, HLI, and HI tests carried out with two different measles virus strains, Edmonston and a strain (LEC) derived from a case of SSPE. Comparison of antibodies against measles virus products and, as a reference, against a group-specific vertex capsomer antigen of adenovirus in matched serum and CSF samples revealed a production of measles virus-specific antibodies within the central nervous system of all cases of SSPE and 8 out of 15 cases of MS.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4629257      PMCID: PMC422523          DOI: 10.1128/iai.6.3.248-254.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Presence of 2 different viral agents in brain cells of patients with subacute sclerosing panencephalitis.

Authors:  G Barbanti-Brodano; S Oyanagi; M Katz; H Koprowski
Journal:  Proc Soc Exp Biol Med       Date:  1970-05

2.  A new serological technique for identification of adenovirus infections.

Authors:  E Norrby; J van der Veen; A Espmark
Journal:  Proc Soc Exp Biol Med       Date:  1970-07

3.  Measles-virus antibody and antigen in subacute sclerosing panencephalitis.

Authors:  J H Connolly; I V Allen; L J Hurwitz; J H Millar
Journal:  Lancet       Date:  1967-03-11       Impact factor: 79.321

4.  Virus antibody levels in multiple sclerosis.

Authors:  C A Ross; J A Lenman; I D Melville
Journal:  Br Med J       Date:  1969-08-30

5.  Additional data on measles virus antibody and antigen in subacute sclerosing panencephalitis.

Authors:  J H Connolly
Journal:  Neurology       Date:  1968-01       Impact factor: 9.910

6.  Measles antibody titers in multiple sclerosis patients, siblings, and controls.

Authors:  T E Henson; J A Brody; J L Sever; M L Dyken; J Cannon
Journal:  JAMA       Date:  1970-03-23       Impact factor: 56.272

7.  Measles antibodies in patients with multiple sclerosis and with other neurological and nonneurological diseases.

Authors:  J M Adams; M B Brooks; E D Fisher; C S Tyler
Journal:  Neurology       Date:  1970-10       Impact factor: 9.910

8.  Gel precipitation reactions between alkaline extracted rubella antigens and human sera.

Authors:  A A Salmi
Journal:  Acta Pathol Microbiol Scand       Date:  1969

9.  Measles antibodies in patients with multiple sclerosis.

Authors:  J M Adams
Journal:  Neurology       Date:  1967-07       Impact factor: 9.910

10.  Immunoglobulin M specific for measles and mumps in multiple sclerosis.

Authors:  J H Millar; K B Fraser; M Haire; J H Connolly; P V Shirodaria; D S Hadden
Journal:  Br Med J       Date:  1971-05-15
View more
  32 in total

1.  Measles-virus-specific IgG in optic neuritis and in multiple sclerosis after optic neuritis.

Authors:  W M Hutchinson; M Haire
Journal:  Br Med J       Date:  1976-01-10

Review 2.  Subacute sclerosing panencephalitis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  2002-02       Impact factor: 2.401

3.  Transient appearance of oligoclonal immunoglobulins and measles virus antibodies in the cerebrospinal fluid in a case of acute measles encephalitis.

Authors:  B Sköldenberg; A Carlström; M Forsgren; E Norrby
Journal:  Clin Exp Immunol       Date:  1976-03       Impact factor: 4.330

4.  A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.

Authors:  R C Collins; L R Espinoza; C R Plank; G C Ebers; R A Rosenberg; J B Zabriskie
Journal:  Clin Exp Immunol       Date:  1978-07       Impact factor: 4.330

Review 5.  Measles virus and its associated diseases.

Authors:  E M Morgan; F Rapp
Journal:  Bacteriol Rev       Date:  1977-09

6.  Characterization of measles virus-specific antibodies in sera from patients with chronic active hepatitis.

Authors:  K E Christie; C Endresen; G Haukenes
Journal:  J Hyg (Lond)       Date:  1982-06

7.  Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies.

Authors:  E Norrby; Y Gollmar
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

8.  Prevalence of measles antibodies in patients with subacute sclerosing panencephalitis in Poland in the years 1971--1978.

Authors:  I Polna; J Wyszkowski; J Kulczycki; A Szcześniak; H Abramowicz
Journal:  J Neurol       Date:  1980       Impact factor: 4.849

9.  Age dependence of viral expression: comparative pathogenesis of two rodent-adapted strains of measles virus in mice.

Authors:  D E Griffin; J Mullinix; O Narayan; R T Johnson
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

10.  Immunoperoxidase stain of measles antigen in tissue culture.

Authors:  M Dubois-Dalcq; L H Barbosa
Journal:  J Virol       Date:  1973-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.